Background:  bFGF, also called FGF2 or heparin-binding growth factor 2 (hbgf-2) or prostatropin. The heparin-binding growth factors are angiogenic agents in vivo and are potent mitogens for a variety of cell types in vitro. There are differences in the tissue distribution and concentration of these 2 growth factors. activates the MAP kinase signaling pathway; plays a role in synaptic transmission; induces cell proliferation. This protein binds heparin more strongly than does aFGF. It belongs to the heparin-binding growth factors family.

Description: Rabbit polyclonal to bFGF

Immunogen: KLH conjugated synthetic peptide derived from bFGF

Specificity:  ·Reacts with Human, Mouse and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 18 kDa;

·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;

·Immunocytochemistry/Immunofluorescence: 1/100;

·Immunoprecipitation: 1/50;

·ELISA: 1/500;

·Optimal working dilutions must be determined by the end user.